These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 32633419)
41. NLRC5: new cancer buster? Tang F; Xu Y; Zhao B Mol Biol Rep; 2020 Mar; 47(3):2265-2277. PubMed ID: 31925644 [TBL] [Abstract][Full Text] [Related]
42. Patient-derived organoid biobank identifies epigenetic dysregulation of intestinal epithelial MHC-I as a novel mechanism in severe Crohn's Disease. Dennison TW; Edgar RD; Payne F; Nayak KM; Ross ADB; Cenier A; Glemas C; Giachero F; Foster AR; Harris R; Kraiczy J; Salvestrini C; Stavrou G; Torrente F; Brook K; Trayers C; Elmentaite R; Youssef G; Tél B; Winton DJ; Skoufou-Papoutsaki N; Adler S; Bufler P; Azabdaftari A; Jenke A; G N; Thomas N; Miele E; Al-Mohammad A; Guarda G; Kugathasan S; Venkateswaran S; Clatworthy MR; Castro-Dopico T; Suchanek O; Strisciuglio C; Gasparetto M; Lee S; Xu X; Bello E; Han N; Zerbino DR; Teichmann SA; Nys J; Heuschkel R; Perrone F; Zilbauer M Gut; 2024 Aug; 73(9):1464-1477. PubMed ID: 38857990 [TBL] [Abstract][Full Text] [Related]
43. NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens. Rodriguez GM; Yakubovich E; Murshed H; Maranda V; Galpin KJC; Cudmore A; Hanna AMR; Macdonald E; Ramesh S; Garson K; Vanderhyden BC Front Immunol; 2023; 14():1295208. PubMed ID: 38235131 [TBL] [Abstract][Full Text] [Related]
44. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667 [TBL] [Abstract][Full Text] [Related]
47. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells. Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904 [TBL] [Abstract][Full Text] [Related]
48. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Dhatchinamoorthy K; Colbert JD; Rock KL Front Immunol; 2021; 12():636568. PubMed ID: 33767702 [TBL] [Abstract][Full Text] [Related]
49. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity. Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328 [TBL] [Abstract][Full Text] [Related]
50. Expression of MHC II genes. Drozina G; Kohoutek J; Jabrane-Ferrat N; Peterlin BM Curr Top Microbiol Immunol; 2005; 290():147-70. PubMed ID: 16480042 [TBL] [Abstract][Full Text] [Related]
51. NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients. Li X; Guo F; Liu Y; Chen HJ; Wen F; Zou B; Li D; Qin Q; Liu X; Shen Y; Wang Y Oncol Lett; 2015 Sep; 10(3):1533-1540. PubMed ID: 26622704 [TBL] [Abstract][Full Text] [Related]
52. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Yoo JS; Sasaki M; Cho SX; Kasuga Y; Zhu B; Ouda R; Orba Y; de Figueiredo P; Sawa H; Kobayashi KS Nat Commun; 2021 Nov; 12(1):6602. PubMed ID: 34782627 [TBL] [Abstract][Full Text] [Related]
53. Identification and expressional analysis of NLRC5 inflammasome gene in smolting Atlantic salmon (Salmo salar). Pontigo JP; Agüero MJ; Sánchez P; Oyarzún R; Vargas-Lagos C; Mancilla J; Kossmann H; Morera FJ; Yáñez AJ; Vargas-Chacoff L Fish Shellfish Immunol; 2016 Nov; 58():259-265. PubMed ID: 27640334 [TBL] [Abstract][Full Text] [Related]
54. Induction of MHC class I expression by the MHC class II transactivator CIITA. Martin BK; Chin KC; Olsen JC; Skinner CA; Dey A; Ozato K; Ting JP Immunity; 1997 May; 6(5):591-600. PubMed ID: 9175837 [TBL] [Abstract][Full Text] [Related]
55. The Obligate Intracellular Bacterium Rodino KG; Adcox HE; Martin RK; Patel V; Conrad DH; Carlyon JA Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30559222 [No Abstract] [Full Text] [Related]
56. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression. Bhat KP; Truax AD; Brooks JK; Greer SF Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748 [TBL] [Abstract][Full Text] [Related]
57. MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator. Naves R; Lennon AM; Barbieri G; Reyes L; Puga G; Salas L; Deffrennes V; Rosemblatt M; Fellous M; Charron D; Alcaïde-Loridan C; Bono MR Int Immunol; 2002 May; 14(5):481-91. PubMed ID: 11978778 [TBL] [Abstract][Full Text] [Related]
58. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W; Tang LP; Dong Y; Benveniste EN J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712 [TBL] [Abstract][Full Text] [Related]
59. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Zika E; Greer SF; Zhu XS; Ting JP Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811 [TBL] [Abstract][Full Text] [Related]
60. BMI1 induces ubiquitination and protein degradation of Nod-like receptor family CARD domain containing 5 and suppresses human leukocyte antigen class I expression to induce immune escape in non-small cell lung cancer. Lu ZH; Tu GJ; Fu SL; Shang K; Peng SJ; Chen L; Gu XJ Kaohsiung J Med Sci; 2022 Dec; 38(12):1190-1202. PubMed ID: 36194200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]